CreditReports.dk
HomeScreen companies

SIMULPHARMA ApS Financials, key figures and credit report

CVR number: 32832075 Established 2010 Industry: 46 Wholesale trade
Company contact details
Marievej 24, 2950 Vedbæk gulli@simulpharma.com tel: 51828267
Net sales 159.0 kDKK FY 2024 +38.2% vs 2023
EBIT margin 25.9 % FY 2024 +75.8 pp vs 2023
Net debt -64.8 kDKK FY 2024 -188.4% vs 2023
Quick ratio 6.1 FY 2024

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales719.00636.00484.00114.98158.96
External services- 105.00-78.00
Gross profit719.00636.00406.00-57.3441.20
Costs of management- 590.00- 615.00- 464.00- 172.32- 117.76
Costs of distribution-86.00
EBIT43.00-84.00-58.00-57.3441.20
Other financial income0.10
Other financial expenses-1.00
Pre-tax profit43.00-85.00-58.00-57.3441.29
Income taxes-6.002.00
Net earnings37.00-83.00-58.00-57.3441.29

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Prepayments and accrued income11.00
Current other receivables4.004.96
Short term receivables total15.004.96
Cash and bank deposits230.00138.0090.0022.4871.44
Cash and cash equivalents230.00138.0090.0022.4871.44
Balance sheet total (assets)245.00138.0090.0022.4876.39

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital80.0080.0080.0080.0080.00
Retained earnings105.00141.0058.00-0.18-57.52
Profit of the financial year37.00-83.00-58.00-57.3441.29
Shareholders equity total222.00138.0080.0022.4863.77
Non-current liabilities total
Current loans from credit institutions6.60
Current trade creditors6.00
Short-term deferred tax liabilities6.00
Other non-interest bearing current liabilities0.02
Accruals and deferred income17.0010.00
Current liabilities total23.0010.0012.63
Balance sheet total (liabilities)245.00138.0090.0022.4876.39
Page generated